PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of genannJournal InfoAuthorsPermissionsJournals.ASM.orggenomeA ArticleGenome Announcements
 
Genome Announc. 2017 April; 5(14): e00107-17.
Published online 2017 April 6. doi:  10.1128/genomeA.00107-17
PMCID: PMC5383888

Genome Sequences of Potential Probiotic Lactobacillus rhamnosus Isolates from Human Infants

ABSTRACT

Probiotics provide health benefits to their hosts, including modulation of host immune response, inhibition of colonization by pathogens, modulation of the gut microbiota, and epithelial barrier enhancement. Here, we present the draft genome sequences of two newly isolated Lactobacillus rhamnosus strains of probiotic potential from healthy human infants.

GENOME ANNOUNCEMENT

Probiotics are live microbes that confer a benefit to their hosts when administered in adequate amounts (1). Support for the use of probiotics as interventions for gastrointestinal diseases is increasing (2,4). Most of the diversity of the gut microbiome exists at the strain level (5), calling for more in-depth studies of individual bacterial strains to assess phenotypes that could have a beneficial impact. Lactobacillus rhamnosus is a lactic acid bacterium with probiotic properties when associated with the host gut (6) or skin (7). Here, we report the genome sequences of two novel strains of L. rhamnosus isolated from stool samples from healthy human infants (8).

We isolated 175 bacterial strains from stool samples from healthy infants (0 to 2 years old) (8). Each strain was initially isolated by plating stool samples from healthy human infants on de Man, Rogosa, and Sharpe (MRS) agar plates (Hardy Diagnostics, Santa Maria, CA) under anaerobic conditions, separating individual colonies. Subsequently, single colonies were selected and grown in MRS broth. Phylogenetic identification of isolates was performed by sequencing of the 16S rRNA gene, and selected isolates were further characterized by random amplification of polymorphic DNA (RAPD) (9, 10) to identify unique strains. Two novel L. rhamnosus isolates (AMC010 and AMC143) were identified in this study.

Genomic DNA from AMC010 and AMC143 was isolated using UltraClean microbial DNA isolation kit (Mo Bio). AMC010 was subjected to sequencing on the Ion Torrent PGM platform (Life Technologies, Inc.), generating sequence data of 485.3 Mb over 3,022,036 reads, with an average read length of 160 bp, providing 43× coverage of the 3.14-Mb genome. AMC143 genomic DNA (gDNA) was sequenced on the Roche FLX Titanium platform, generating 69.4 Mb of sequence over 318,612 reads, with an average read length of 210 bp, providing 23× coverage of the 2.87-Mb genome. Raw reads were quality filtered and assembled using Newbler (Roche) (11). Assembled contigs were annotated using an updated version of the GAMOLA annotation pipeline (12).

AMC010 has a G+C content of 46.6%, 53 annotated tRNA genes, and 3,171 annotated coding sequences (CDSs), with 162 unique genes compared to other sequenced and annotated L. rhamnosus genomes using the EDGAR genome analysis software (13). In addition to uncharacterized hypothetical proteins, AMC010 contains a unique toxin-antitoxin pair and unique bacteriophage components. AMC143 has a G+C content of 46.6%, 47 annotated tRNA genes, and 2,835 annotated CDSs, with 73 unique genes compared to other sequenced and annotated L. rhamnosus genomes. Included among these unique genes are bacteriophage components, a phosphotransferase (PTS) fructose transporter system, PTS lactose transporter system, and a large number of previously uncharacterized hypothetical proteins.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under accession numbers MSTB00000000 (AMC143) and MSTC00000000 (AMC010).

ACKNOWLEDGMENT

The Microbiome Core Facility is supported in part by NIH grant P30 DK34987.

Footnotes

Citation Arnold JW, Monteagudo-Mera A, Altermann E, Cadenas MB, Thompson AL, Azcarate-Peril MA. 2017. Genome sequences of potential probiotic Lactobacillus rhamnosus isolates from human infants. Genome Announc 5:e00107-17. https://doi.org/10.1128/genomeA.00107-17.

REFERENCES

1. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37:105–118. [PubMed]
2. Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M 2006. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol 100:1324–1332. doi:.10.1111/j.1365-2672.2006.02857.x [PubMed] [Cross Ref]
3. Gao Z, Guo B, Gao R, Zhu Q, Wu W, Qin H 2015. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Mol Med Rep 12:6119–6127. doi:.10.3892/mmr.2015.4124 [PubMed] [Cross Ref]
4. Nami Y, Haghshenas B, Abdullah N, Barzegari A, Radiah D, Rosli R, Khosroushahi AY 2015. Probiotics or antibiotics: future challenges in medicine. J Med Microbiol 64:137–146. doi:.10.1099/jmm.0.078923-0 [PubMed] [Cross Ref]
5. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA 2005. Diversity of the human intestinal microbial flora. Science 308:1635–1638. doi:.10.1126/science.1110591 [PMC free article] [PubMed] [Cross Ref]
6. Doron S, Snydman DR, Gorbach SL 2005. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34:483–498, ix. doi:.10.1016/j.gtc.2005.05.011 [PubMed] [Cross Ref]
7. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389–395. [PubMed]
8. Thompson AL, Monteagudo-Mera A, Cadenas MB, Lampl ML, Azcarate-Peril MA 2015. Milk- and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiome. Front Cell Infect Microbiol 5:3. doi:.10.3389/fcimb.2015.00003 [PMC free article] [PubMed] [Cross Ref]
9. Du Plessis EM, Dicks LM 1995. Evaluation of random amplified polymorphic DNA (RAPD)-PCR as a method to differentiate Lactobacillus acidophilus, Lactobacillus crispatus, Lactobacillus amylovorus, Lactobacillus gallinarum, Lactobacillus gasseri, and Lactobacillus johnsonii. Curr Microbiol 31:114–118. [PubMed]
10. Williams JG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV 1990. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 18:6531–6535. [PMC free article] [PubMed]
11. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothber RM 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376–380. doi:.10.1038/nature03959 [PMC free article] [PubMed] [Cross Ref]
12. Altermann E, Klaenhammer TR 2003. GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. Omics 7:161–169. doi:.10.1089/153623103322246557 [PubMed] [Cross Ref]
13. Aras K, Good W, Tate J, Burton B, Brooks D, Coll-Font J, Doessel O, Schulze W, Potyagaylo D, Wang L, van Dam P, MacLeod R 2015. Experimental Data and Geometric Analysis Repository-EDGAR. J Electrocardiol 48:975–981. doi:.10.1016/j.jelectrocard.2015.08.008 [PMC free article] [PubMed] [Cross Ref]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)